Catalys Pacific

Cayman Islands Founded: 2019 • Age: 7 yrs
Invests in biotech companies via global networks and partnerships for disease treatments.

About Catalys Pacific

Catalys Pacific is a Financial Services company based in Cayman Islands founded in 2019. Invests in biotech companies via global networks and partnerships for disease treatments. It operates on a Venture Capital and Partnership-based Investment model in Financial Services and Healthcare sectors. Catalys Pacific offers products and services including Investment Services and Company Building. Its focus areas include Biotech, Investment, Early-Stage Funding and Therapeutics.

Company details

Catalys Pacific is an investment firm that builds biotech companies by leveraging transpacific partnerships between Japan and the United States. It focuses on accessing early-stage opportunities in areas like hypertension and renal disease treatments. With offices in Tokyo and Seattle, the firm develops therapies to improve patient outcomes while generating returns for investors through strategic investments and local networks.

  • Headquarters Cayman Islands
  • Sectors
    Financial Services
    Healthcare
  • Website catalyspacific.com

Products & Services of Catalys Pacific

Catalys Pacific offers a comprehensive portfolio of products and services, including Investment Services and Company Building.

Investment Services
Venture Capital

Provides funding and support for early-stage biotech startups

Company Building
Biotech Development

Facilitates creation of biotech firms through partnerships

People of Catalys Pacific

16 people are tracked at Catalys Pacific (7 in leadership, 5 in board & advisors, 4 in team).

NameRoleGroup
Yuki Makihira
Vice PresidentLeadership
BT Slingsby
Founder & Managing DirectorLeadership
Neal Fowler
Operating PartnerLeadership
Maki Haginoya
Vice PresidentLeadership
Jay Shepard
Venture PartnerLeadership
Takeshi Takahashi
Managing DirectorLeadership
Forrest H. Fuller
Executive Vice President Of Strategy And Business Development For Portfolio Companies In JapanLeadership
Jonathan MacQuitty
Industry AdvisorBoard & advisors
Nobuo Hanai
Industry AdvisorBoard & advisors
Seth H Z Fischer
AdvisorBoard & advisors
Norihiko Ishihara
Industry AdvisorBoard & advisors
Ryan Drant
Industry AdvisorBoard & advisors
Keisuke Kobayashi
PrincipalTeam
Hiromi Miwa
Senior AnalystTeam
Megumi Nagata
AssociateTeam
Hiromi M.
Senior AnalystTeam
Premium access

Complete people profiles for Catalys Pacific

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Web traffic of Catalys Pacific

The website of Catalys Pacific (catalyspacific.com) receives about 3.7K visits a month.

  • Monthly visits
    3.7K

    ▲ 5.6% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Catalys Pacific

Premium access

Complete news archive for Catalys Pacific

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Catalys Pacific

Catalys Pacific was founded in 2019.

Catalys Pacific is headquartered in Cayman Islands.

Catalys Pacific is an investment firm that builds biotech companies by leveraging transpacific partnerships between Japan and the United States. It focuses on accessing early-stage opportunities in areas like hypertension and renal disease treatments. With offices in Tokyo and Seattle, the firm develops therapies to improve patient outcomes while generating returns for investors through strategic investments and local networks.

Catalys Pacific offers Investment Services and Company Building.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available